Success Stories: EB-1A Approved for Visiting Researcher in the Field of Cancer Pharmacology and Toxicology
Client’s Testimonial:
Thank you for your hard work. It has been a pleasure to work with you. I will definitely recommend your firm.
On March 4, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Visiting Researcher in the Field of Cancer Pharmacology and Toxicology (Approval Notice)
Position at the Time of Case Filing: Visiting Researcher
Country of Origin: China
Service Center: Texas Service Center (TSC)
Approval Notice Date: March 4th, 2015
Processing Time: 7 Days (Premium Processing Requested)
A pharmacologist from China who worked in cancer research was our client in this case. Her specialized research had focused on anti-cancer drug and therapeutics development. Her body of work comprised 50 peer-reviewed scientific articles, 2 book chapters, 6 review articles, and 26 presentations at national and international conferences, a prolific and impressive record; by the time we filed her case, her research had received no fewer than 1936 citations from independent and leading researchers at prestigious institutions and organizations around the world, a strong indication of the major significance of her work. She has also performed peer-review service for 16 distinctive, internationally-circulated journals, reviewing at least 96 manuscripts. It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that she sought to remain in the United States to continue work in the area of Cancer Pharmacology and Toxicology, and that her continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, her case was approved in just seven days.